News Summary: FDA panel backs diet drug lorcaserin

AP News

5/10/2012 6:29:26 PM - AP News

18 THUMBS UP: FDA advisers vote 18-4 to recommend the agency approve sales of lorcaserin, which could be the country's first new prescription diet drug in over a decade.

STOCK SURGE: Shares nearly doubled in after-hours trading, as lorcaserin could become the small company's first approved product.

NEXT STEPS: Maker Arena Pharmaceuticals says it will work with the FDA as it finishes its review, with a June 27 target for a final decision. The agency had rejected lorcaserin in 2010 over possible heart risks, but Arena tried again with additional data.